ANNEXON, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ANNEXON, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $31.01M.
- ANNEXON, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $32.69M.
- ANNEXON, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $13.49M.
- ANNEXON, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $6.13M.
- ANNEXON, INC. stock issued during period, value, new issues for fiscal 2025 was $27.43M, a 35.98% decline from fiscal 2024.
- ANNEXON, INC. stock issued during period, value, new issues for fiscal 2024 was $42.84M.
- ANNEXON, INC. stock issued during period, value, new issues for fiscal 2020 was $262.44M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $31.01M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $32.69M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $27.43M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $13.49M 10-Q · filed 2025-11-10 | |
| 2024-12-31 | $42.84M 10-K · filed 2026-03-30 | |
| 2024-06-30 | $6.13M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $32.20M 10-Q · filed 2025-11-10 | |
| 2023-03-31 | $17.47M 10-Q · filed 2023-11-13 | |
| 2022-09-30 | $122.62M 10-Q · filed 2023-11-13 | |
| 2020-12-31 | $262.44M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $262.44M 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |